Todd M. Stevens
Papers
1
Total Citations
15
H-Index
1
About
Dr. Todd M. Stevens is a leading surgical oncologist whose research focuses on advancing precision surgery for head and neck cancers, particularly oropharyngeal squamous cell carcinoma (OPSCC). His major contributions center on integrating molecular imaging with robotic surgery to improve tumor visualization and resection accuracy. In his landmark 2024 study, Dr. Stevens demonstrated the interim Phase II results of using Panitumumab-IRDye800CW—a fluorescent antibody targeting EGFR—during transoral robotic surgery (TORS) for OPSCC patients. This work addresses a critical challenge: TORS improves functional outcomes over open surgery but limits tactile feedback, making it difficult for surgeons to distinguish cancerous from healthy tissue. By enabling real-time, intraoperative fluorescence guidance, his research has the potential to reduce positive margins and improve patient outcomes. With 15 citations already in its first year, this study has quickly gained attention for its translational impact. Dr. Stevens’ work sits at the intersection of surgical innovation, molecular imaging, and oncology, offering a promising path toward safer, more effective robotic surgeries for head and neck cancer patients.
Research Focus
Key Achievements
Top Papers
- 1